Unbound MEDLINE

Sacroiliitis and severe disability due to isotretinoin therapy. Rheumatology international [Rheumatol Int] Journal article

 
TitleSacroiliitis and severe disability due to isotretinoin therapy.
Author(s)Rozin AP, Kagna O, Shiller Y 
InstitutionB. Shine Department of Rheumatology, Rambam Health Care Campus and Technion, POB 9602, 31096, Haifa, Israel, a_rozin@rambam.health.gov.il.
SourceRheumatol Int 2009 Jun 17.
AbstractWe report a case of acute sacroiliitis with severe disability after only 3 weeks of isotretinoin therapy with graduate reduction of pain, limitation and muscle incompetence after discontinuation of the drug and ACTH-depo injection and Ethodolac therapy. Naranjo probability scale indicated a probable relationship between isotretinoin therapy and bilateral sacroiliitis. We discussed possible mechanisms of sacroiliitis and disability due to isotretinoin treatment.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19533139
  
Advertise on this site.